Skip to main content
WK

www.kchealth.com.cn

Inactive

The startup develops a multi-omics detection and data storage platform that integrates high-throughput single-cell metabolomics and artificial intelligence to facilitate personalized health management in biomedicine. Their technology addresses the need for precise metabolic profiling and immune cell analysis, enabling the development of targeted therapies for various health conditions.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current methods for personalized health management lack comprehensive tools for precise metabolic profiling and immune cell analysis. This limits the ability to develop targeted therapies and proactive health strategies for various conditions.

Solution

The company offers a multi-omics detection and data storage platform that integrates high-throughput single-cell metabolomics with artificial intelligence to enable personalized health management. The platform leverages advanced technologies, including single-cell metabolomics, spatial metabolomics, and high-resolution live-cell imaging, to provide a comprehensive view of an individual's health status. By combining these multi-dimensional data sets with AI-driven analytics, the platform identifies novel drug targets and facilitates the development of innovative cell and small-molecule therapies. The platform supports personalized research projects, cell-based drug development, and small molecule drug development.

Target Audience

The primary target audience includes researchers, healthcare providers, and pharmaceutical companies focused on personalized medicine, drug discovery, and proactive health management.

Features

  • High-throughput single-cell metabolomics analysis platform for detailed metabolic profiling.
  • Spatial metabolomics analysis platform for understanding metabolic activity in specific tissue locations.
  • Non-targeted/Targeted metabolomics analysis platform for comprehensive metabolic analysis.
  • High spatiotemporal resolution live-cell imaging platform for dynamic cellular observation.
  • Cell typing and sorting platform for precise cell isolation and analysis.
  • Molecular and biochemical research platform for in-depth molecular studies.
  • GMP-grade cell preparation platform for clinical-grade cell production.
  • AI-driven data platform for advanced analytics and personalized insights.
This profile is AI-generated and may contain inaccuracies.